BioSpace News Archive

Charles River Laboratories International, Inc. will release fourth-quarter and full-year 2019 financial results and provide 2020 guidance on Tuesday, February 11th, before the market opens.

Because every minute counts when children’s lives are at stake, Deloitte and Rady Children’s Institute for Genomic Medicine (RCIGM) are exploring an innovative approach to cut the time it takes to get medical samples to the laboratory using unmanned aircraft systems (UAS).

Sterifre Medical, Inc., today announced that it is now an official Strategic Partner of the Association for Professionals in Infection Control and Epidemiology (APIC).

Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that Allegheny General Hospital, Pittsburgh, Pa., part of Allegheny Health Network (AHN), has selected Omnicell’s Central Pharmacy IV Compounding Service, a comprehensive, turnkey approach for insourcing some sterile compounding operations.

MTF Biologics, a global nonprofit organization dedicated to saving and healing lives through organ and tissue donation, today announced a partnership with Net Health, the leading provider of cloud-based software for specialized care

Bayer will present new research from the Company’s oncology portfolio, including Stivarga® (regorafenib) and Vitrakvi® (larotrectinib), at the 2020 American Society of Clinical Oncology Gastrointestinal (ASCO GI) Cancers Symposium, taking place January 23-25 in San Francisco, California.

InnerScope Hearing Technologies Inc. (OTCQB: INND) (“InnerScope”) a manufacturer and Direct-to-Consumer (“DTC”) distributor/retailer of FDA-Registered Hearing Aids, Personal Sound Amplifiers Products (“Hearing Products”), Hearing Related Treatment Therapies, Doctor-Formulated Dietary Hearing Supplements and proprietary CBD Oil (“Hearing Health Products”) (collectively “Hearing Product Portfolio), today announced its unaudited annual revenue results ended December 31, 2019 of $1,034,791

Emmes today announced that the Food and Drug Administration (FDA) has extended the labeling of ampicillin, a commonly used antibiotic, to include use in infants younger than 28 days in the treatment of serious conditions meningitis and septicemia

EarlySense, the global leader in contact-free, continuous monitoring solutions for the healthcare continuum, announced today it has been selected to join the TeXchange2020 Health Innovation Program, an initiative of the UK Israel Tech Hub based in the British Embassy in Israel.

Vallon Pharmaceuticals Inc., a specialty pharmaceutical company focused on the development of novel drugs for CNS disorders, today announced the presentation of positive data from a pilot study assessing human abuse liability for its investigational Abuse Deterrent Amphetamine Immediate Release (ADAIR)